Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Clinical trial NCT06467344 · RECRUITING
Trial details
- NCT number
- NCT06467344
- Sponsor
- Ascidian Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-11
- Primary completion
- 2030-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.